KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NERV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Minerva Neurosciences stock downgraded after the last trading session.
(Updated on Apr 26, 2024)

Sell candidate since Apr 26, 2024 PDF

The Minerva Neurosciences stock price gained 0.267% on the last trading day (Friday, 26th Apr 2024), rising from $2.43 to $2.44. During the last trading day the stock fluctuated 2.47% from a day low at $2.43 to a day high of $2.49. The price has fallen in 6 of the last 10 days and is down by -2.54% for this period. Volume fell on the last day by -2 thousand shares and in total, 4 thousand shares were bought and sold for approximately $10.06 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NERV Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 0.682%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Minerva Neurosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.49 and $2.58. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Minerva Neurosciences stock

Minerva Neurosciences finds support from accumulated volume at $2.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.0600 between high and low, or 2.47%. For the last week the stock has had daily average volatility of 3.57%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NERV) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Minerva Neurosciences to open at $2.45, and during the day (based on 14 day Average True Range), to move between $2.24 and $2.64, which gives a possible trading interval of +/-$0.199 (+/-8.18%) up or down from last closing price. If Minerva Neurosciences takes out the full calculated possible swing range there will be an estimated 16.35% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.43 (0.27%) than the resistance at $2.63 (7.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Minerva Neurosciences stock A Buy?

Minerva Neurosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.414 Sell Candidate Downgraded

Predicted Opening Price for Minerva Neurosciences of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$2.45 ( 0.643%) $2.44

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NERV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.51 3.11 %
R2 2.49 2.16 %
R1 2.48 1.58 %
Current price: 2.44
Support S1 2.43 -0.298 %
S2 2.42 -0.88 %
S3 2.39 -1.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.83 16.15 %
R2 2.80 14.92 %
R1 2.63 7.94 %
Current price 2.44
Support S1 2.43 -0.267%
S2 2.42 -0.677%
S3 0 .

FAQ

What is the symbol for Minerva Neurosciences Stock and on which exchange is it traded?
The symbol for Minerva Neurosciences is NERV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Minerva Neurosciences Stock?
Minerva Neurosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Minerva Neurosciences Stock?
Minerva Neurosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Minerva Neurosciences Stock.

What's the current price of Minerva Neurosciences Stock?
As of the end of day on the Apr 26, 2024, the price of an Minerva Neurosciences (NERV) share was $2.44.

What is the 52-week high and low for Minerva Neurosciences Stock?
The 52-week high for Minerva Neurosciences Stock is $13.49 and the 52-week low is $2.30.

What is the market capitalization of Minerva Neurosciences Stock?
As of the Apr 26, 2024, the market capitalization of Minerva Neurosciences is 16.994M.

When is the next earnings date for Minerva Neurosciences?
The upcoming earnings date for Minerva Neurosciences is May 20, 2024.
Click to get the best stock tips daily for free!

About Minerva Neurosciences

Minerva Neurosciences Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, ... NERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT